Welcome to Peptide Card of AntiTbPdb
| This page displays user query in tabular form. |
GNNRPVYIPRPRPPHPRL details |
| Primary information | |
|---|---|
| ID | antitb_2004, |
| Name | US 0222268 A1/E |
| N-Terminal modification | Api . Ib RlO (Al 8 A5) |
| C-Terminal Modification | GNNRPVYIPRPRPPHPRL |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 18 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Strain | Mycobaclerium vaccae |
| Inhibition Concentration | Mycobacterium vaccae |
| In Vitro/ In vivo | Mycobacterium vaccae |
| Cell Line | MIC = 125 |
| Inhibition Concentration | In vitro |
| Sequence | 2010 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | Anti bacterial against - Eschericha coli 45849 and D31, - Klebsiella pneumoniae 123132 and K6,Salmonella typhi S5 and Salmonella enterica subsp. enterica serovar Typhimurium, Rhizobium radiobacter, Klebsiella pneumoniae, Bactillus subtillis |
| Tertiary Structure (Technique) | Not Predicted), |
| Primary information | |
|---|---|
| ID | antitb_2005, |
| Name | US 0222268 A1/E |
| N-Terminal modification | Api Ib RlO acety. (A18 A5 ac ) |
| C-Terminal Modification | GNNRPVYIPRPRPPHPRL |
| Chemical Modification | Acetylation |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 18 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Strain | Mycobaclerium vaccae |
| Inhibition Concentration | Mycobacterium vaccae |
| In Vitro/ In vivo | Mycobacterium vaccae |
| Cell Line | MIC = 125 |
| Inhibition Concentration | In vitro |
| Sequence | 2010 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | Anti bacterial against - Eschericha coli 45849 and D31, - Klebsiella pneumoniae 123132 and K6,Salmonella typhi S5 and Salmonella enterica subsp. enterica serovar Typhimurium, Rhizobium radiobacter, Klebsiella pneumoniae, Bactillus subtillis |
| Tertiary Structure (Technique) | Not Predicted), |